The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
about
Multidisciplinary management of clear-cell renal cell carcinoma in Africa and the Middle East: current practice and recommendations for improvementGastrointestinal Involvement of Recurrent Renal Cell Carcinoma: CT Findings and Clinicopathologic Features.Increased Nek1 expression in renal cell carcinoma cells is associated with decreased sensitivity to DNA-damaging treatmentSubcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinomaRetrospective survival analysis of 237 consecutive patients with multiple pulmonary metastases from advanced renal cell carcinoma exclusively resected by a 1318-nm laser.IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer.IL-8 induces the epithelial-mesenchymal transition of renal cell carcinoma cells through the activation of AKT signaling.Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma.Mortality trends and the impact of lymphadenectomy on survival for renal cell carcinoma patients with distant metastasis.A Synchronous Pancreatic Metastasis from Renal Clear Cell Carcinoma, with Unusual CT Characteristics, Completely Regressed after Therapy with Sunitinib.New challenges in kidney cancer management: integration of surgery and novel therapies.Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma.22-year survival following radical nephrectomy and several metastasectomies in a case of renal cell carcinomaDoes solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study.Cytoreductive nephrectomy in the era of targeted therapies: a review.Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy.Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients.Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma.Renal Clear Cell Carcinoma Acrometastasis. An Unusual Terminal Condition.The treating scenario in genitourinary oncology: what is new? Part 1.Metastasectomy in older adults with urothelial carcinoma: Population-based analysis of use and outcomes.More than 10-year follow-up after total en bloc spondylectomy for spinal tumors.Management of metastatic renal cell carcinoma - mini review.A flexible parametric approach for estimating continuous-time inverse probability of treatment and censoring weights.
P2860
Q26801279-5A689329-595D-4D78-9DBD-98CF9BAC0BB3Q33561385-453EF153-3B92-4AED-A166-D98889E45D26Q34100935-D23CB08E-C003-4321-A688-65531608D597Q35177397-3D69774E-77A7-474F-B27D-5E9E4CD0602DQ35632452-1439E4F6-441B-49B7-B5D3-97B3B2DFF8D9Q35886767-AEBC7B77-D4C6-463E-A905-87E87303229EQ37204389-697638D0-FF30-4596-8593-D10BD79164F5Q37419277-366BC351-7BFD-459A-B2DA-97868EEE6DE5Q37515882-C406C33D-B155-4D30-BF79-E2F5D250E8A6Q37674132-3519B168-F0B0-47F9-A8EE-335C170FB495Q38381788-8C89F013-6738-4D86-AA2E-EFDFB4FE0291Q38543085-D9D2AC52-F335-4337-9819-9ED8436D0C66Q38674642-A736ACD1-C3E6-4BA4-83E1-4C86AD779F85Q38722330-973A3DC8-B881-494E-909C-33ECDAD69C91Q38749318-7F2BB130-E60A-4F1A-807F-0B712FC88B44Q39216342-BE59D1C6-8EE5-46F2-96DD-C2C874992547Q40591422-13737BA3-D3BE-4EF2-AC10-DD32EF8C5840Q40812617-3A985283-C4EF-4805-9B2C-1A5081EA7E68Q41503446-BA3EEB1F-AD0E-4FAA-9954-13FB737AD6CFQ42047551-BF66CEC7-2627-41F1-BC11-D087C3FFC211Q44834803-06AC19EF-720B-4522-9CAB-2C966F468779Q48028604-A37AF741-04DF-41E8-B072-99708FC5DB76Q50683323-8B113B3B-5FFD-4336-B556-11A02DE11A8FQ53848926-596D6FFB-B57C-4E44-80B3-87874FCCF60FQ54232256-C1691D21-521C-4537-A293-5E99F36BBC49
P2860
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
@ast
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
@en
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
@nl
type
label
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
@ast
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
@en
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
@nl
prefLabel
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
@ast
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
@en
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
@nl
P2860
P1476
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
@en
P2860
P2888
P356
10.1007/S11934-012-0293-6
P577
2013-02-01T00:00:00Z
P6179
1020686840